30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

GANNON STEVEN

Track

Insider profile

Performance

Overall performance
3.8
Performance over holding periods
3.8
30 days 90 days 120 days
Average return 12% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
8 38% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
GANNON STEVEN's trades of Xenon Pharmaceuticals Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-06-06 2025-06-05
S Sale
85,257 -3.3%
480.74
US$2,432,990 		85,257 -3.3% 480.74 US$2,432,990
2024-03-08 2024-03-07
S Sale
46,275 -30.3%
492.16
US$4,304,575 		46,275 -30.3% 492.16 US$4,304,575
2024-03-08 2024-03-07
S Sale
44,264 -8.0%
67.89
US$204,903 		44,264 -8.0% 67.89 US$204,903
2024-03-08 2024-03-07
S Sale
5,000 -35.7%
46.25
US$231,250 		5,000 -35.7% 46.25 US$231,250
2024-03-08 2024-03-07
S Sale
1,000 -6.7%
46.45
US$46,450 		1,000 -6.7% 46.45 US$46,450
2024-03-07 2024-03-07
PrS Proposed sale
13,000
46.18
US$600,310 		13,000 46.18 US$600,310
2022-08-11 2022-08-11
B Purchase
44,400 +370.0%
2.03
US$90,132 		44,400 +370.0% 2.03 US$90,132
2021-08-20 2021-08-19
B Purchase
3,000 +48.6%
8.05
US$24,150 		3,000 +48.6% 8.05 US$24,150
2021-08-20 2021-08-18
B Purchase
171 +2.9%
8.05
US$1,377 		171 +2.9% 8.05 US$1,377